Medicines / Eli Lilly and Company (India) / Cyramza
CyramzaRamucirumab
Cyramza is marketed by Eli Lilly and Company (India). 2 packs on NPPA's price list for July 2026, containing Ramucirumab.
- Packs listed
- 2
- Lowest MRP
- ₹48,324
- Per unit
- ₹4,829 to ₹4,832
- Price-controlled packs
- 0 of 2
- Dosage forms
- 1
Packs and prices
- ₹241,436Cyramza 500 mg Injection 50 mlRamucirumab Injection 500 mg · ₹4,829 per ml
- ₹48,324Cyramza 100 mg Injection 10 mlRamucirumab Injection 100 mg · ₹4,832 per ml
The company
Eli Lilly and Company (India) has 31 packs on the price list. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.